Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Ceapro

    Client Virtual Booth

    CEAPRO

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Ceapro
    Canada Flag
    Country
    Country
    Canada
    Address
    Address
    7824-51 Avenue NW Edmonton, Alberta T6E 6W2
    Telephone
    Telephone
    780.421.4555
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ceapro.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ceapro
    Twitter
    Twitter
    https://twitter.com/CeaproInc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Aeterna Zentaris & Ceapro Merger Approved by Securityholders at Special Meetings
    Aeterna Zentaris & Ceapro Merger Approved by Securityholders at Special Meetings

    https://www.globenewswire.com//news-release/2024/03/12/2844946/0/en/Aeterna-Zentaris-and-Ceapro-Merger-Approved-by-Securityholders-at-Special-Meetings.html

    GLOBENEWSWIRE
    12 Mar 2024
    Share Share
    Ceapro Provides Business Update on Progress of Ongoing Development Programs
    Ceapro Provides Business Update on Progress of Ongoing Development Programs

    https://www.globenewswire.com//news-release/2024/02/23/2834482/0/en/Ceapro-Provides-Business-Update-on-Progress-of-Ongoing-Development-Programs-Technology-and-Cosmeceutical-Base-Business.html

    GLOBENEWSWIRE
    23 Feb 2024
    Share Share
    Ceapro Inc. Announces the Mailing of Meeting Materials
    Ceapro Inc. Announces the Mailing of Meeting Materials

    https://www.globenewswire.com//news-release/2024/02/15/2830459/0/en/Ceapro-Inc-Announces-the-Mailing-of-Meeting-Materials-in-Connection-With-the-Special-Meeting-of-Securityholders-to-Approve-Merger-With-Aeterna-Zentaris.html

    GLOBENEWSWIRE
    15 Feb 2024
    Share Share
    Aeterna Zentaris and Ceapro Announce Merger of Equals
    Aeterna Zentaris and Ceapro Announce Merger of Equals

    https://www.globenewswire.com//news-release/2023/12/14/2796184/0/en/Aeterna-Zentaris-and-Ceapro-Announce-Merger-of-Equals-to-Create-a-Diversified-Biopharmaceutical-Company.html

    GLOBENEWSWIRE
    14 Dec 2023
    Share Share
    Ceapro Announces Dosing of First Patients in Ph 1-2a Assessing Avenanthramides
    Ceapro Announces Dosing of First Patients in Ph 1-2a Assessing Avenanthramides

    https://www.globenewswire.com//news-release/2023/12/13/2795574/0/en/Ceapro-Inc-Announces-Dosing-of-First-Patients-in-Phase-1-2a-Study-Assessing-Flagship-Product-Avenanthramides-for-Potential-Applications-in-Inflammation-Based-Diseases.html

    GLOBENEWSWIRE
    13 Dec 2023
    Share Share
    Ceapro Inc. Reports 2023 Third Quarter Financial Results
    Ceapro Inc. Reports 2023 Third Quarter Financial Results

    https://www.globenewswire.com//news-release/2023/11/29/2787836/0/en/Ceapro-Inc-Reports-2023-Third-Quarter-and-Nine-Month-Financial-Results-and-Operational-Highlights.html

    GLOBENEWSWIRE
    29 Nov 2023
    Share Share
    Ceapro Initiates Phase 1-2a Study Assessing Flagship Product Avenanthramides
    Ceapro Initiates Phase 1-2a Study Assessing Flagship Product Avenanthramides

    https://www.globenewswire.com//news-release/2023/11/27/2786260/0/en/Ceapro-Inc-Initiates-Phase-1-2a-Study-Assessing-Its-Flagship-Product-Avenanthramides-for-Potential-Applications-in-Inflammation-Based-Diseases.html

    GLOBENEWSWIRE
    27 Nov 2023
    Share Share
    Ceapro Enters into Technical Collaboration with NATEX Prozesstechnologie GmbH
    Ceapro Enters into Technical Collaboration with NATEX Prozesstechnologie GmbH

    https://www.globenewswire.com//news-release/2023/11/07/2775087/0/en/Ceapro-Inc-Enters-into-Technical-Collaboration-with-NATEX-Prozesstechnologie-GmbH-and-Provides-Update-on-the-Scale-Up-Project-for-its-Patented-Pressurized-Gas-eXpanded-PGX-Technolo.html

    GLOBENEWSWIRE
    07 Nov 2023
    Share Share
    Ceapro Inc. Reports 2023 Second Quarter and Six-Month Financial Results
    Ceapro Inc. Reports 2023 Second Quarter and Six-Month Financial Results

    https://www.globenewswire.com//news-release/2023/08/29/2733501/0/en/Ceapro-Inc-Reports-2023-Second-Quarter-and-Six-Month-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    29 Aug 2023
    Share Share
    Ceapro Extends International Supply and Distribution Agreement with Symrise
    Ceapro Extends International Supply and Distribution Agreement with Symrise

    https://www.globenewswire.com//news-release/2023/08/25/2731871/0/en/Ceapro-Extends-Exclusive-International-Supply-and-Distribution-Agreement-with-Leading-Global-Provider-of-Active-Ingredients-Symrise.html

    GLOBENEWSWIRE
    25 Aug 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search